Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S ribosomal subunit decoding center is a fundamental functional domain within the bacterial ribosome, primarily composed of highly conserved regions of the 16S ribosomal RNA (rRNA). Its primary biological role is to ensure translational fidelity by monitoring the base-pairing between the mRNA codon and the tRNA anticodon at the aminoacyl (A) site (Source: PubMed, PMID: 11054804). When a cognate tRNA is recognized, the decoding center undergoes a specific conformational change involving the flipping out of two adenine residues (A1492 and A1493), which signals the ribosome to proceed with peptide bond formation (Source: Nature, 2000). This site is the therapeutic target for several major classes of antibiotics used to treat bacterial infections. Aminoglycosides bind directly to the decoding center, locking it in a state that accepts near-cognate tRNAs, leading to the production of mistranslated, non-functional proteins that eventually cause bacterial cell death (Source: StatPearls, 2023). Tetracyclines also target the 30S subunit but act by physically preventing the docking of aminoacyl-tRNA, thereby halting protein synthesis (Source: PubChem). Because the decoding center is essential for bacterial survival, it is a critical focus for overcoming antibiotic resistance, particularly against strains that modify the site through methylation or mutation (Source: NIH, 2021).
Inhibition of bacterial protein synthesis by either inducing mRNA misreading through stabilization of the out-of-conformation state of A1492 and A1493 (aminoglycosides) or by sterically blocking the binding of aminoacyl-tRNA to the A-site (tetracyclines).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S ribosomal subunit decoding center (30S decoding center).